Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutation Selection during In Vitro Exposure to Tenofovir Alone or Combined with Abacavir or Lamivudine

Documenti analoghi

• Reversion of the M184V Mutation in Simian Immunodeficiency Virus Reverse Transcriptase Is Selected by Tenofovir, Even in the Presence of Lamivudine
  di: Murry, Jeffrey P., et al.
  Pubblicazione: (2003)
• In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine
  di: Margot, N. A., et al.
  Pubblicazione: (2006)
• Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir
  di: Marchand, Bruno, et al.
  Pubblicazione: (2007)
• Pressure of Zidovudine Accelerates the Reversion of Lamivudine Resistance-Conferring M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1
  di: Diallo, Karidia, et al.
  Pubblicazione: (2002)
• Zidovudine, Lamivudine, and Abacavir Have Different Effects on Resting Cells Infected with Human Immunodeficiency Virus In Vitro
  di: Saavedra-Lozano, Jesús, et al.
  Pubblicazione: (2004)